For decades, CSL was the golden child of the ASX, the great Australian success story: a privatised government entity turned global biotech titan.

One day after CSL suddenly replaced its CEO, the company provided dismal financial figures that helped explain why. | One day after CSL revealed that it had suddenly replaced its CEO, the company ...

Formerly the Commonwealth Serum Laboratories, CSL grew under McNamee into a world leader in blood fractionation, where plasma ...

With pressure piling on for CSL, the Australian vaccine and plasma specialist has elected to part ways with its CEO on the ...

From a student in Iloilo to an internationally recognized authority in vaccinology, Dr. Melvin Sanicas, is an expert who not ...

The SEC sued a Kentucky pharmaceutical company and two former executives for allegedly misleading investors about a cancer drug’s FDA approval status while raising $4.1 million. CBA Pharma Inc. and ...

SpyGlass Pharma Inc. shares jumped 65% in the biopharmaceutical firm’s trading debut after it raised $150 million in an initial public offering. The company’s shares closed at $26.40 each in New York ...

Allentown, Pa. — A global pharmaceutical company plans to invest billions in Pennsylvania to build a manufacturing facility. On Friday, Governor Josh Shapiro and Pennsylvania Department of Community & ...

Halo Pharma, a CDMO specializing in drug product pharmaceutical development and manufacturing services, will become a stand-alone business as a result of the sale of the Noramco API and associated ...

Aerial view of a Plano water tower on Windhaven Parkway near Parkwood Boulevard and Spring Creek Parkway on Monday, Aug. 21, 2023, in Plano. A mixed used development is planned on farm land owned by ...

Pete Pharma, a leader in pharmaceutical innovation and pharmaceutical IP development, is proud to announce a strategic partnership with Curexa, a nationally recognized 503A pharmacy serving a growing ...

Ongoing clinical results with ratutrelvir confirm a differentiated profile versus PAXLOVID ® with fewer adverse events, no viral rebounds to date and faster time to sustained symptom resolution; ...